Dopamine and fear memory formation in the human amygdala.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
03 2022
Historique:
received: 24 06 2021
accepted: 23 11 2021
revised: 12 11 2021
pubmed: 5 12 2021
medline: 18 5 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

Learning which environmental cues that predict danger is crucial for survival and accomplished through Pavlovian fear conditioning. In humans and rodents alike, fear conditioning is amygdala-dependent and rests on similar neurocircuitry. Rodent studies have implicated a causative role for dopamine in the amygdala during fear memory formation, but the role of dopamine in aversive learning in humans is unclear. Here, we show dopamine release in the amygdala and striatum during fear learning in humans. Using simultaneous positron emission tomography and functional magnetic resonance imaging, we demonstrate that the amount of dopamine release is linked to strength of conditioned fear responses and linearly coupled to learning-induced activity in the amygdala. Thus, like in rodents, formation of amygdala-dependent fear memories in humans seems to be facilitated by endogenous dopamine release, supporting an evolutionary conserved neurochemical mechanism for aversive memory formation.

Identifiants

pubmed: 34862441
doi: 10.1038/s41380-021-01400-x
pii: 10.1038/s41380-021-01400-x
pmc: PMC9095491
doi:

Substances chimiques

Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1704-1711

Informations de copyright

© 2021. The Author(s).

Références

LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155–84.
pubmed: 10845062 doi: 10.1146/annurev.neuro.23.1.155
Agren T, Engman J, Frick A, Björkstrand J, Larsson E-M, Furmark T, et al. Disruption of reconsolidation erases a fear memory trace in the human amygdala. Science. 2012;337:1550–2.
pubmed: 22997340 doi: 10.1126/science.1223006
Johansen JP, Cain CK, Ostroff LE, LeDoux JE. Molecular mechanisms of fear learning and memory. Cell. 2011;147:509–24.
pubmed: 22036561 pmcid: 3215943 doi: 10.1016/j.cell.2011.10.009
LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron. 1998;20:937–45.
pubmed: 9620698 doi: 10.1016/S0896-6273(00)80475-4
Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. 2004;5:483–94.
pubmed: 15152198 doi: 10.1038/nrn1406
Murty VP, Ritchey M, Adcock RA, LaBar KS. fMRI studies of successful emotional memory encoding: a quantitative meta-analysis. Neuropsychologia. 2010;48:3459–69.
pubmed: 20688087 pmcid: 2949536 doi: 10.1016/j.neuropsychologia.2010.07.030
de la Mora MP, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis. Prog Neurobiol. 2010;90:198–216.
pubmed: 19853006 doi: 10.1016/j.pneurobio.2009.10.010
Jo YS, Heymann G, Zweifel LS. Dopamine neurons reflect the uncertainty in fear generalization. Neuron. 2018;100:916–25.e3.
pubmed: 30318411 doi: 10.1016/j.neuron.2018.09.028
Guarraci FA, Frohardt RJ, Kapp BS. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res. 1999;827:28–40.
pubmed: 10320690 doi: 10.1016/S0006-8993(99)01291-3
Guarraci FA, Frohardt RJ, Falls WA, Kapp BS. The effects of intra-amygdaloid infusions of a D
pubmed: 10883814 doi: 10.1037/0735-7044.114.3.647
Greba Q, Gifkins A, Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 2001;899:218–26.
pubmed: 11311883 doi: 10.1016/S0006-8993(01)02243-0
Kim JJ, Jung MW. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev. 2006;30:188–202.
pubmed: 16120461 doi: 10.1016/j.neubiorev.2005.06.005
Fadok JP, Dickerson TMK, Palmiter RD. Dopamine is necessary for Cue-dependent fear conditioning. J Neurosci. 2009;29:11089–97.
pubmed: 19741115 pmcid: 2759996 doi: 10.1523/JNEUROSCI.1616-09.2009
Tsai H-C, Zhang F, Adamantidis A, Stuber GD, Bonci A, Lecea Lde, et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science. 2009;324:1080–4.
pubmed: 19389999 pmcid: 5262197 doi: 10.1126/science.1168878
Bäckman L, Nyberg L, Soveri A, Johansson J, Andersson M, Dahlin E, et al. Effects of working-memory training on striatal dopamine release. Science. 2011;333:718–718.
pubmed: 21817043 doi: 10.1126/science.1204978
Aalto S, Brück A, Laine M, Någren K, Rinne JO. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci. 2005;25:2471–7.
pubmed: 15758155 pmcid: 6725173 doi: 10.1523/JNEUROSCI.2097-04.2005
Badgaiyan RD, Fischman AJ, Alpert NM. Striatal dopamine release in sequential learning. NeuroImage. 2007;38:549–56.
pubmed: 17888684 doi: 10.1016/j.neuroimage.2007.07.052
Tessitore A, Hariri AR, Fera F, Smith WG, Chase TN, Hyde TM, et al. Dopamine modulates the response of the human amygdala: a study in Parkinson’s disease. J Neurosci. 2002;22:9099–103.
pubmed: 12388617 pmcid: 6757686 doi: 10.1523/JNEUROSCI.22-20-09099.2002
Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci. 2001;115:358–64.
pubmed: 11345960 doi: 10.1037/0735-7044.115.2.358
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347:1260419.
Karalija N, Jonassson L, Johansson J, Papenberg G, Salami A, Andersson M, et al. High long-term test–retest reliability for extrastriatal 11C-raclopride binding in healthy older adults. J Cereb Blood Flow Metab. 2020;40:1859–68.
Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986;231:258–61.
pubmed: 2867601 doi: 10.1126/science.2867601
Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse. 1996;23:115–23.
pubmed: 8723716 doi: 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C
Lonsdorf TB, Menz MM, Andreatta M, Fullana MA, Golkar A, Haaker J, et al. Don’t fear ‘fear conditioning’: methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear. Neurosci Biobehav Rev. 2017;77:247–85.
pubmed: 28263758 doi: 10.1016/j.neubiorev.2017.02.026
Benedek M, Kaernbach C. A continuous measure of phasic electrodermal activity. J Neurosci Methods. 2010;190:80–91.
pubmed: 20451556 pmcid: 2892750 doi: 10.1016/j.jneumeth.2010.04.028
Boucsein W. Electrodermal activity. New York, NY: Plenum; 1992.
Boucsein W, Fowles DC, Grimnes S, Ben-Shakhar G, Roth WT, Dawson ME, et al. Publication recommendations for electrodermal measurements. Psychophysiology. 2012;49:1017–34.
pubmed: 22680988 doi: 10.1111/j.1469-8986.2012.01384.x
Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbøl S, Frøkjaer VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24:969–79.
pubmed: 15670674 doi: 10.1016/j.neuroimage.2004.10.017
Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage. 1996;4:153–8.
pubmed: 9345505 doi: 10.1006/nimg.1996.0066
Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage. 1997;6:279–87.
pubmed: 9417971 doi: 10.1006/nimg.1997.0303
Normandin MD, Schiffer WK, Morris ED. A linear model for estimation of neurotransmitter response profiles from dynamic PET data. NeuroImage. 2012;59:2689–99.
pubmed: 21767654 doi: 10.1016/j.neuroimage.2011.07.002
Yokoyama M, Suzuki E, Sato T, Maruta S, Watanabe S, Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett. 2005;379:37–41.
pubmed: 15814195 doi: 10.1016/j.neulet.2004.12.047
Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233–9.
pubmed: 12880848 doi: 10.1016/S1053-8119(03)00169-1
Achterberg M, van der Meulen M. Genetic and environmental influences on MRI scan quantity and quality. Developmental Cogn Neurosci. 2019;38:100667.
doi: 10.1016/j.dcn.2019.100667
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
Likhtik E, Johansen JP. Neuromodulation in circuits of aversive emotional learning. Nat Neurosci. 2019;22:1586–97.
pubmed: 31551602 doi: 10.1038/s41593-019-0503-3
Marowsky A, Yanagawa Y, Obata K, Vogt KE. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron. 2005;48:1025–37.
pubmed: 16364905 doi: 10.1016/j.neuron.2005.10.029
Tang W, Kochubey O, Kintscher M, Schneggenburger RA. VTA to basal amygdala dopamine projection contributes to signal salient somatosensory events during fear learning. J Neurosci. 2020;40:3969–80.
pubmed: 32277045 pmcid: 7219297 doi: 10.1523/JNEUROSCI.1796-19.2020
Young AMJ, Joseph MH, Gray JA. Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience. 1993;54:5–9.
pubmed: 8515846 doi: 10.1016/0306-4522(93)90378-S
Lutas A, Kucukdereli H, Alturkistani O, Carty C, Sugden AU, Fernando K, et al. State-specific gating of salient cues by midbrain dopaminergic input to basal amygdala. Nat Neurosci. 2019;22:1820–33.
pubmed: 31611706 pmcid: 6858554 doi: 10.1038/s41593-019-0506-0
Schultz W. Neuronal reward and decision signals: from theories to data. Physiological Rev. 2015;95:853–951.
doi: 10.1152/physrev.00023.2014
Rogan MT, Stäubli UV, LeDoux JE. Fear conditioning induces associative long-term potentiation in the amygdala. Nature. 1997;390:604–7.
pubmed: 9403688 doi: 10.1038/37601
Rossato JI, Bevilaqua LRM, Izquierdo I, Medina JH, Cammarota M. Dopamine controls persistence of long-term memory storage. Science. 2009;325:1017–20.
pubmed: 19696353 doi: 10.1126/science.1172545
De Bundel D, Zussy C, Espallergues J, Gerfen CR, Girault J-A, Valjent E. Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala. Mol Psychiatry. 2016;21:1545–53.
pubmed: 26782052 pmcid: 5101541 doi: 10.1038/mp.2015.210
Lange I, Goossens L, Michielse S, Bakker J, Vervliet B, Marcelis M, et al. Neural responses during extinction learning predict exposure therapy outcome in phobia: results from a randomized-controlled trial. Neuropsychopharmacol. 2020;45:534–41.
doi: 10.1038/s41386-019-0467-8
LaLumiere RT, Nguyen LT, McGaugh JL. Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems. Eur J Neurosci. 2004;20:2804–10.
pubmed: 15548223 doi: 10.1111/j.1460-9568.2004.03744.x
Gerlicher AMV, Tüscher O, Kalisch R. L-DOPA improves extinction memory retrieval after successful fear extinction. Psychopharmacology. 2019;236:3401–12.
pubmed: 31243481 pmcid: 6892771 doi: 10.1007/s00213-019-05301-4
Ardiel EL, Giles AC, Yu AJ, Lindsay TH, Lockery SR, Rankin CH. Dopamine receptor DOP-4 modulates habituation to repetitive photoactivation of a C. elegans polymodal nociceptor. Learn Mem. 2016;23:495–503.
pubmed: 27634141 pmcid: 5026203 doi: 10.1101/lm.041830.116
Nyberg L, Karalija N, Salami A, Andersson M, Wåhlin A, Kaboovand N, et al. Dopamine D2 receptor availability is linked to hippocampal–caudate functional connectivity and episodic memory. PNAS. 2016;113:7918–23.
pubmed: 27339132 pmcid: 4948341 doi: 10.1073/pnas.1606309113

Auteurs

Andreas Frick (A)

The Beijer Laboratory, Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden. andreas.frick@neuro.uu.se.

Johannes Björkstrand (J)

Department of Psychology, Lund University, Lund, Sweden.
Department of Psychology, Uppsala University, Uppsala, Sweden.

Mark Lubberink (M)

Department of Surgical Sciences / Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.

Allison Eriksson (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Mats Fredrikson (M)

Department of Psychology, Uppsala University, Uppsala, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Fredrik Åhs (F)

Department of Psychology and Social Work, Mid Sweden University, Östersund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH